Your browser is no longer supported. Please, upgrade your browser.
ILMN Illumina, Inc. weekly Stock Chart
ILMN [NASD]
Illumina, Inc.
IndexS&P 500 P/E51.72 EPS (ttm)5.77 Insider Own0.40% Shs Outstand149.68M Perf Week-1.33%
Market Cap44.65B Forward P/E40.64 EPS next Y7.34 Insider Trans-14.81% Shs Float146.54M Perf Month-16.81%
Income862.00M PEG3.43 EPS next Q1.34 Inst Own92.60% Short Float1.73% Perf Quarter-6.52%
Sales3.40B P/S13.15 EPS this Y-5.10% Inst Trans0.18% Short Ratio2.21 Perf Half Y-4.63%
Book/sh27.11 P/B11.00 EPS next Y15.07% ROA12.60% Target Price331.43 Perf Year-3.50%
Cash/sh24.15 P/C12.35 EPS next 5Y15.07% ROE23.50% 52W Range268.62 - 380.76 Perf YTD-0.55%
Dividend- P/FCF54.25 EPS past 5Y44.40% ROI13.60% 52W High-21.66% Beta1.08
Dividend %- Quick Ratio3.30 Sales past 5Y18.60% Gross Margin69.10% 52W Low11.04% ATR9.39
Employees7300 Current Ratio3.70 Sales Q/Q8.20% Oper. Margin25.60% RSI (14)29.03 Volatility1.98% 2.10%
OptionableYes Debt/Eq0.44 EPS Q/Q11.30% Profit Margin25.10% Rel Volume1.00 Prev Close293.20
ShortableYes LT Debt/Eq0.28 EarningsJul 29 AMC Payout0.00% Avg Volume1.15M Price298.28
Recom2.10 SMA20-14.16% SMA50-10.10% SMA200-5.64% Volume1,230,419 Change1.73%
Jul-12-19Downgrade BofA/Merrill Buy → Underperform
May-30-19Initiated Wolfe Research Outperform
Jan-03-19Upgrade UBS Neutral → Buy
Oct-09-18Initiated UBS Neutral
Aug-07-18Upgrade Morgan Stanley Underweight → Equal-Weight
Jul-31-18Reiterated Canaccord Genuity Buy $330 → $340
Feb-05-18Upgrade Citigroup Neutral → Buy
Jan-31-18Upgrade First Analysis Sec Equal-Weight → Overweight $277
Jan-05-18Initiated BTIG Research Neutral
Jan-05-18Downgrade William Blair Outperform → Mkt Perform
Jan-02-18Upgrade Wells Fargo Market Perform → Outperform
Oct-25-17Upgrade Robert W. Baird Neutral → Outperform $184 → $228
Oct-23-17Upgrade Janney Sell → Neutral
Oct-23-17Upgrade Deutsche Bank Hold → Buy $195 → $250
Sep-26-17Resumed Goldman Neutral $200
Aug-07-17Upgrade Canaccord Genuity Hold → Buy $170 → $215
Aug-02-17Upgrade First Analysis Sec Underweight → Equal-Weight
Apr-26-17Reiterated Cantor Fitzgerald Neutral $155 → $170
Mar-20-17Upgrade Leerink Partners Mkt Perform → Outperform
Feb-01-17Reiterated UBS Buy $180 → $185
Jul-22-19 05:50PM  Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know Zacks
10:31AM  Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for Zacks
10:06AM  What Happens If Pacific Biosciences Isn't Acquired By Illumina? Motley Fool
Jul-19-19 12:13PM  Here's Why Pacific Biosciences Is Tumbling Today Motley Fool
Jul-18-19 11:26AM  Here's 2 Very Lucrative Trades From My New Trading Venture TheStreet.com
09:30AM  EXEL or ILMN: Which Is the Better Value Stock Right Now? Zacks
Jul-16-19 02:00AM  Illumina Expands Genomics Accelerator to Cambridge, UK Business Wire
Jul-15-19 05:50PM  Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know Zacks
09:31AM  Company News for Jul 15, 2019 Zacks
Jul-12-19 05:05PM  What Happened in the Stock Market Today Motley Fool -16.12%
04:29PM  Nasdaq Today: Amazon Prime Day; Facebook Settles With FTC InvestorPlace
04:25PM  S&P 500, Dow, Nasdaq close at record levels again as bulls bank on Fed rate cut MarketWatch
04:18PM  This Genomics Stock Just Lost A Breakout Why Analysts Still Like It Investor's Business Daily
04:16PM  4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB InvestorPlace
03:46PM  4 Healthcare Stocks That Are Feeling Sick InvestorPlace
03:32PM  Here's Why NanoString Technologies Stock Soared 104.7% in the First Half of 2019 Motley Fool
03:28PM  Illumina nosedives as company cuts revenue outlook Yahoo Finance Video
12:48PM  Illumina News: Why ILMN Stock Is Plummeting InvestorPlace
11:56AM  Stock Market News: Facebook Faces New Crypto Criticism; Illumina's Revenue Falls Short Motley Fool
11:25AM  Why Illumina Stock Is Tanking Today Motley Fool
10:45AM  BofA Double Downgrades Illumina After Thursday's 'Big Miss' Benzinga
10:13AM  Dow Jones Hits Record Highs To Lead Stock Market Rally; Illumina Plunges Investor's Business Daily
10:01AM  Illumina, One of My Short Stock Candidates, Shows Mediocre Growth TheStreet.com
10:00AM  Illumina's stock tumbles after revenue warning prompts double downgrade at BofA Merrill Lynch MarketWatch
09:04AM  Illumina Stock Is Plummeting but Analysts Still Favor Genome Company Barrons.com
09:01AM  Illumina Stock Plunges While the Dow Is Rising for a Third Day Barrons.com
07:58AM  Dow Jones Futures: Illumina, Profitable Marijuana Stock Tumble; Amgen-Novartis Alzheimer's Drug Fails Investor's Business Daily
07:24AM  The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study Benzinga
06:08AM  Will Illumina, Inc.'s (NASDAQ:ILMN) Earnings Grow Over The Next Year? Simply Wall St.
05:57AM  Illumina Plunges on Lower Second-Quarter Guidance TheStreet.com
Jul-11-19 09:39PM  After Hours: Illumina Issues a Warning, Colgate-Palmolive Makes an Acquisition Motley Fool
04:26PM  Illumina stock plunges more than 14% after genetics company lowers guidance MarketWatch
04:05PM  Illumina Reports Preliminary Revenue for Second Quarter of Fiscal Year 2019 Business Wire
12:02PM  California biotech takes 13,000 square feet at UM BioPark American City Business Journals
11:10AM  Illumina (ILMN) Grows on Innovation & International Growth Zacks
Jul-10-19 04:23PM  DOJ and SEC charge accountant and friend with insider trading MarketWatch
Jul-09-19 05:50PM  Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-08-19 10:34AM  Illumina (ILMN) Hits 52-Week High, Can the Run Continue? Zacks
Jul-07-19 12:16PM  5 Great Stocks to Buy in July Motley Fool
07:00AM  Oxford Nanopore opens DNA decoding kit factory Financial Times
05:00AM  As 'Precision Medicine' Starts to Take Off, Here's Who's Poised to Capitalize TheStreet.com
Jul-04-19 06:09PM  Why Illumina Stock Jumped 20% in June Motley Fool
Jul-03-19 07:17PM  Illumina Inc (ILMN) President and CEO Francis A Desouza Sold $1.1 million of Shares GuruFocus.com
05:45PM  Illumina (ILMN) Outpaces Stock Market Gains: What You Should Know Zacks
Jul-02-19 06:18PM  Five Runaway Breakout Stocks to Buy Zacks
03:40PM  Baron Capital Commentary: Early Detection for the Win GuruFocus.com
Jul-01-19 02:02PM  Is Now An Opportune Moment To Examine Illumina, Inc. (NASDAQ:ILMN)? Simply Wall St.
Jun-28-19 09:00AM  Illumina Files Patent Infringement Suits Related to BGI in Switzerland, Turkey and the US Business Wire
Jun-25-19 05:50PM  Illumina (ILMN) Gains As Market Dips: What You Should Know Zacks
05:18PM  Best Growth Stocks for July 2019 Investopedia
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
Jun-21-19 10:42AM  The Zacks Analyst Blog Highlights: Invitae, Illumina, Pacific Biosciences and Guardant Health Zacks
10:37AM  The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International Zacks
Jun-20-19 09:18AM  5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints Zacks
Jun-19-19 06:41PM  46 and You: Genetic Testing = Giant Growth Market Zacks
09:15AM  They Meet, We Rally Zacks
Jun-18-19 05:45PM  Illumina (ILMN) Stock Sinks As Market Gains: What You Should Know Zacks
10:09AM  Pacific Bio Shares Fall on U.K. Antitrust Concern About Illumina Deal TheStreet.com
Jun-17-19 04:05PM  Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc. Business Wire
Jun-14-19 11:02AM  Moving Average Crossover Alert: Illumina Zacks
09:30AM  GILD vs. ILMN: Which Stock Is the Better Value Option? Zacks
09:23AM  Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion Zacks
Jun-12-19 05:50PM  Illumina (ILMN) Gains As Market Dips: What You Should Know Zacks
10:03AM  The Zacks Analyst Blog Highlights: American International, Arconic, Hasbro, Illumina and Jefferies Zacks
Jun-11-19 07:47AM  5 Top S&P 500 Stocks to Fly High Despite Market Volatility Zacks
07:17AM  Better Buy: Illumina vs. Guardant Health Motley Fool
Jun-10-19 08:19PM  Heres What Hedge Funds Think About Illumina, Inc. (ILMN) Insider Monkey
Jun-09-19 12:15PM  3 Healthcare Stocks I'd Buy Right Now Motley Fool
Jun-07-19 04:43PM  Getting technical: Stocks love the 'Fed put'; Tesla still in a down trend traders to sell the rally Yahoo Finance Video +5.31%
Jun-06-19 05:45PM  Illumina (ILMN) Gains But Lags Market: What You Should Know Zacks
01:55PM  Top 5 Stocks in the Fight Against Cancer Motley Fool
Jun-05-19 09:44AM  The Zacks Analyst Blog Highlights: Vertex Pharmaceuticals, Gilead Sciences, Repligen, Illumina and Bio-Techne Zacks
Jun-04-19 03:02PM  Is Illumina, Inc.'s (NASDAQ:ILMN) ROE Of 20% Impressive? Simply Wall St.
02:12PM  5 Biotech Stocks to Buy Right Now Zacks
09:00AM  Illumina Introduces Expanded Version of VeriSeq NIPT Solution, Offering More Comprehensive Detection of Rare Chromosomal Conditions Business Wire
May-30-19 06:53AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
May-29-19 04:05PM  Illumina to Webcast Upcoming Investor Conference Presentation Business Wire
09:30AM  GILD or ILMN: Which Is the Better Value Stock Right Now? Zacks
May-28-19 11:18AM  Why Illumina (ILMN) Could Be an Impressive Growth Stock Zacks
09:47AM  Illumina, Wix.com, Microsoft, Facebook and Oracle highlighted as Zacks Bull and Bear of the Day Zacks
08:46AM  The Zacks Analyst Blog Highlights: Guardant, Illumina, Exact Sciences and Pfizer Zacks
05:43AM  Bull of the Day: Illumina (ILMN) Zacks
May-25-19 09:31AM  Illumina (ILMN) Down 2.1% Since Last Earnings Report: Can It Rebound? Zacks
May-24-19 09:25AM  3 Stocks to Win Big in the Fight Against Cancer Zacks
May-23-19 09:30AM  Has Illumina (ILMN) Outpaced Other Medical Stocks This Year? Zacks
08:15AM  3 Cancer Treatment Stocks to Buy Right Now Motley Fool
May-21-19 06:11AM  Who's Winning the Race for This $100 Billion Healthcare Market? Motley Fool
May-20-19 07:40AM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
May-19-19 12:23PM  3 Healthcare Stocks I'd Buy Right Now Motley Fool
10:53AM  Top 5 Health Care Stocks of 2018 by Performance Investopedia
May-17-19 02:34PM  Final trades: Illumina, Home Depot & Colgate CNBC Videos
May-16-19 10:37PM  UK life science companies show signs of health Financial Times
May-15-19 09:00AM  Illumina Files Patent Infringement Suit Against BGI in Denmark Business Wire
May-14-19 01:50PM  Is Illumina, Inc.'s (NASDAQ:ILMN) CEO Overpaid Relative To Its Peers? Simply Wall St.
May-13-19 09:30AM  GILD vs. ILMN: Which Stock Is the Better Value Option? Zacks
08:41AM  Here's Why You Should Invest in Illumina (ILMN) Stock Now Zacks
May-08-19 08:45PM  3 Stocks to Buy and Hold for Decades Motley Fool
02:32PM  Human lifespan could soon pass 100 years thanks to medical tech, says BofA CNBC
01:54PM  Final Trades: Disney, Illumina, Impinj & Gold CNBC Videos
11:00AM  App Store for DNA Fizzles as Health Startup Shifts Strategy Bloomberg
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as enables the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. has a partnership with Lundbeck Foundation GeoGenetics Centre for exploring the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens; and an agreement with HTG Molecular Diagnostics, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ronaghi MostafaSVP & CTOJul 15Option Exercise69.3410,000693,40086,776Jul 18 11:38 AM
Ronaghi MostafaSVP & CTOJul 15Sale302.0410,0003,020,39276,776Jul 18 11:38 AM
FLATLEY JAY TDirectorJul 10Sale376.503,3001,242,450272,616Jul 12 06:19 PM
deSouza Francis APresident and CEOJul 01Sale369.553,0001,108,65564,936Jul 03 04:50 PM
Dadswell CharlesSVP & General CounselJul 01Sale371.2912446,0406,679Jul 03 04:47 PM
FLATLEY JAY TDirectorJun 26Sale358.153,3001,181,895275,916Jun 28 04:06 PM
Ronaghi MostafaSVP & CTOJun 17Option Exercise69.3410,000693,40086,776Jun 19 07:07 PM
Ronaghi MostafaSVP & CTOJun 17Sale349.2810,0003,492,75376,776Jun 19 07:07 PM
FLATLEY JAY TDirectorJun 12Sale334.533,3001,103,949279,216Jun 14 04:00 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanJun 10Sale335.031,260422,13811,945Jun 12 04:05 PM
deSouza Francis APresident and CEOJun 03Sale309.693,000929,08067,936Jun 05 04:34 PM
Dadswell CharlesSVP & General CounselJun 03Sale309.701,220377,8386,866Jun 05 04:27 PM
FLATLEY JAY TDirectorMay 22Sale304.443,3001,004,652282,516May 24 05:22 PM
Ronaghi MostafaSVP & CTOMay 15Option Exercise69.3410,000693,40087,414May 16 08:34 PM
Ronaghi MostafaSVP & CTOMay 15Sale305.4910,0003,054,87677,414May 16 08:34 PM
ARNOLD FRANCESDirectorMay 13Sale307.951,503462,84910,159May 15 04:44 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanMay 10Sale315.321,260397,30313,205May 13 07:42 PM
FLATLEY JAY TDirectorMay 08Sale318.593,3001,051,347285,816May 10 05:50 PM
EPSTEIN ROBERT SDirectorMay 01Option Exercise51.175,000255,8508,256May 03 05:18 PM
EPSTEIN ROBERT SDirectorMay 01Sale310.445,0001,552,1783,256May 03 05:18 PM
deSouza Francis APresident and CEOMay 01Sale310.013,000930,02970,936May 03 05:12 PM
Dadswell CharlesSVP & General CounselMay 01Sale311.7712438,6598,086May 03 05:07 PM
FLATLEY JAY TDirectorApr 24Sale321.963,3001,062,468289,116Apr 26 05:29 PM
FLATLEY JAY TDirectorApr 10Sale317.013,3001,046,133331,668Apr 12 04:33 PM
EPSTEIN ROBERT SDirectorApr 01Option Exercise51.171,00051,1704,256Apr 03 05:28 PM
deSouza Francis APresident and CEOApr 01Sale315.933,000947,78873,746Apr 03 05:25 PM
Dadswell CharlesSVP & General CounselApr 01Sale314.4512438,9928,210Apr 03 05:22 PM
EPSTEIN ROBERT SDirectorApr 01Sale314.451,000314,4503,256Apr 03 05:28 PM
FLATLEY JAY TDirectorMar 27Sale306.933,3001,012,869334,968Mar 29 04:01 PM
FLATLEY JAY TDirectorMar 13Sale306.503,3001,011,450338,268Mar 29 04:01 PM
EPSTEIN ROBERT SDirectorMar 01Option Exercise51.171,00051,1704,256Mar 05 04:57 PM
deSouza Francis APresident and CEOMar 01Sale316.513,000949,51876,746Mar 05 04:58 PM
Dadswell CharlesSVP & General CounselMar 01Sale313.931,220382,9958,334Mar 05 04:56 PM
EPSTEIN ROBERT SDirectorMar 01Sale313.931,000313,9303,256Mar 05 04:57 PM
FLATLEY JAY TDirectorFeb 27Sale300.003,300990,000341,568Mar 01 05:23 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 26Sale304.6329890,7802,297Feb 28 05:30 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanFeb 15Sale294.621,260371,21629,420Feb 19 07:02 PM
FLATLEY JAY TDirectorFeb 13Sale293.663,300969,078344,868Feb 14 04:21 PM
Van Oene MarkSVP Chief Commercial OfficerFeb 12Option Exercise0.005,639015,419Feb 14 04:36 PM
Ronaghi MostafaSVP & CTOFeb 12Option Exercise0.009,782079,217Feb 14 04:34 PM
RAGUSA ROBERT PSVP, Global Quality & OpsFeb 12Option Exercise0.004,540015,316Feb 14 04:32 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanFeb 12Option Exercise0.009,492033,875Feb 14 04:23 PM
FLATLEY JAY TDirectorFeb 12Option Exercise0.0028,8880358,929Feb 14 04:21 PM
deSouza Francis APresident and CEOFeb 12Option Exercise0.0024,621082,910Feb 14 04:17 PM
Dadswell CharlesSVP & General CounselFeb 12Option Exercise0.004,127011,064Feb 14 04:15 PM
EPSTEIN ROBERT SDirectorFeb 01Option Exercise51.171,00051,1704,256Feb 05 04:45 PM
Dadswell CharlesSVP & General CounselFeb 01Sale280.1112434,7346,879Feb 05 04:44 PM
deSouza Francis APresident and CEOFeb 01Sale282.953,000848,85464,104Feb 05 04:46 PM
EPSTEIN ROBERT SDirectorFeb 01Sale280.111,000280,1103,256Feb 05 04:45 PM
FLATLEY JAY TDirectorJan 23Sale303.533,3001,001,649329,979Jan 25 04:27 PM
FLATLEY JAY TDirectorJan 09Sale296.203,300977,460333,279Jan 11 04:35 PM
EASTHAM KARINDirectorJan 02Option Exercise71.094,000284,36015,838Jan 04 05:03 PM
EPSTEIN ROBERT SDirectorJan 02Option Exercise51.171,00051,1704,256Jan 04 05:05 PM
EPSTEIN ROBERT SDirectorJan 02Sale294.711,000294,7103,256Jan 04 05:05 PM
deSouza Francis APresident and CEOJan 02Sale293.333,000879,99467,104Jan 04 05:04 PM
EASTHAM KARINDirectorJan 02Sale294.085,0001,470,38110,838Jan 04 05:03 PM
Dadswell CharlesSr VP & General CounselJan 02Sale294.7112436,5447,003Jan 04 05:01 PM
FLATLEY JAY TDirectorDec 26Sale273.873,300903,771336,579Dec 28 05:36 PM
FLATLEY JAY TDirectorDec 12Sale334.133,3001,102,629371,559Dec 13 07:26 PM
OSTADAN OMEADEVP Ops, Products, StrategyDec 10Sale321.50644207,04621,613Dec 12 01:59 PM
Stapley MarcEVP Strategy & Corp DevelopmtDec 06Sale329.691,000329,6956,957Dec 07 05:17 PM
EPSTEIN ROBERT SDirectorDec 03Option Exercise51.171,00051,1706,101Dec 04 09:03 PM
EPSTEIN ROBERT SDirectorDec 03Sale343.571,345462,1024,756Dec 04 09:03 PM
Dadswell CharlesSr VP & General CounselDec 03Sale343.57566194,4615,606Dec 04 09:01 PM
deSouza Francis APresident and CEODec 03Sale345.903,0001,037,68863,643Dec 04 09:02 PM
FLATLEY JAY TDirectorNov 28Sale321.803,3001,061,940373,410Nov 30 04:24 PM
OSTADAN OMEADEVP Ops, Products, StrategyNov 23Sale306.74644197,54122,257Nov 27 04:39 PM
FLATLEY JAY TDirectorNov 14Sale312.503,3001,031,250376,710Nov 16 04:09 PM
Ronaghi MostafaSr VP & CTONov 12Option Exercise37.0410,000370,40079,612Nov 14 05:44 PM
Ronaghi MostafaSr VP & CTONov 12Sale314.6310,0003,146,33769,612Nov 14 05:44 PM
Stapley MarcEVP Strategy & Corp DevelopmtNov 07Sale336.681,000336,6806,957Nov 09 04:23 PM
Van Oene MarkSVP Chief Commercial OfficerNov 05Option Exercise29.446,000176,64017,126Nov 07 05:05 PM
Van Oene MarkSVP Chief Commercial OfficerNov 05Sale326.116,8352,228,95010,291Nov 07 05:05 PM
EPSTEIN ROBERT SDirectorNov 01Option Exercise51.171,00051,1706,447Nov 02 05:01 PM
EPSTEIN ROBERT SDirectorNov 01Sale311.861,346419,7645,101Nov 02 05:01 PM
deSouza Francis APresident and CEONov 01Sale310.852,100652,78870,235Nov 02 05:03 PM
FLATLEY JAY TDirectorOct 24Sale310.583,3001,024,914382,304Oct 26 04:35 PM
Ronaghi MostafaSr VP & CTOOct 10Option Exercise37.0410,000370,40080,805Oct 12 04:37 PM
Ronaghi MostafaSr VP & CTOOct 10Sale311.8410,0003,118,42470,805Oct 12 04:37 PM
FLATLEY JAY TDirectorOct 10Sale321.583,3001,061,214385,604Oct 12 04:35 PM
EPSTEIN ROBERT SDirectorOct 01Option Exercise51.171,00051,1706,793Oct 03 04:17 PM
deSouza Francis APresident and CEOOct 01Sale369.612,100776,18372,335Oct 03 04:20 PM
EPSTEIN ROBERT SDirectorOct 01Sale369.151,346496,8765,447Oct 03 04:17 PM
FLATLEY JAY TDirectorSep 26Sale360.813,3001,190,673388,904Sep 28 05:29 PM
FLATLEY JAY TDirectorSep 12Sale351.663,3001,160,478392,204Sep 14 09:25 PM
Ronaghi MostafaSr VP & CTOSep 10Option Exercise37.0410,000370,40080,805Sep 11 05:49 PM
Ronaghi MostafaSr VP & CTOSep 10Sale347.0710,0003,470,70970,805Sep 11 05:49 PM
EPSTEIN ROBERT SDirectorSep 07Option Exercise51.171,00051,1707,139Sep 11 05:45 PM
EPSTEIN ROBERT SDirectorSep 07Sale345.141,346464,5585,793Sep 11 05:45 PM
Stapley MarcEVP Strategy & Corp DevelopmtSep 04Sale352.051,000352,0548,516Sep 06 08:22 PM
deSouza Francis APresident and CEOSep 04Sale353.662,100742,68674,435Sep 06 06:26 PM
Van Oene MarkSVP Chief Commercial OfficerSep 04Sale354.181,091386,41011,126Sep 06 06:09 PM
Ronaghi MostafaSr VP & CTOAug 10Option Exercise37.0410,000370,40080,805Aug 14 04:07 PM
Ronaghi MostafaSr VP & CTOAug 10Sale331.3910,0003,313,86170,805Aug 14 04:07 PM
OSTADAN OMEADEVP Ops, Products, StrategyAug 02Sale320.701,334427,81424,484Aug 06 08:11 PM
Stapley MarcEVP Strategy & Corp DevelopmtAug 02Sale324.801,000324,7987,516Aug 06 08:10 PM
deSouza Francis APresident and CEOAug 01Sale327.412,100687,55576,535Aug 03 03:03 PM